Tocilizumab: A novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases

被引：59

作者：

Alten, Rieke ^{[1
]}

Maleitzke, Tazio ^{[1
]}

机构：

[1] Univ Med Berlin, Schlosspk Klin, D-10459 Berlin, Germany

来源：

ANNALS OF MEDICINE | 2013年 / 45卷 / 04期

关键词：

Interleukin-6; monoclonal receptor antibody; rare diseases; rheumatic diseases; rheumatoid arthritis; tocilizumab; GIANT-CELL ARTERITIS; SERONEGATIVE SYMMETRICAL SYNOVITIS; LARGE-VESSEL VASCULITIS; ONSET STILLS-DISEASE; ANKYLOSING-SPONDYLITIS; POLYMYALGIA-RHEUMATICA; TAKAYASU ARTERITIS; AA AMYLOIDOSIS; PITTING EDEMA; RELAPSING POLYCHONDRITIS;

D O I：

10.3109/07853890.2013.771986

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Tocilizumab is a highly effective therapeutic agent for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis. Furthermore, a large amount of case study data reveals that tocilizumab can be an effective therapy for not only rheumatoid arthritis but also for other mostly rare inflammatory rheumatic diseases. By blocking the interleukin-6 pathway tocilizumab can be a useful therapeutic alternative when conventional treatment fails. It is successful in treating diseases such as the adult-onset Still's disease, amyloidosis, giant cell arteritis, multiple myeloma, polymyalgia rheumatica, relapsing polychondritis, remitting seronegative symmetrical synovitis with pitting edema-syndrome, systemic lupus erythematosus, systemic sclerosis, and Takayasu arteritis. Studies underway are now recruiting patients to acquire further data on treating patients with non-rheumatic arthritis, inflammatory diseases. This review focuses on tocilizumab as a promising agent for treating rare and orphan diseases in rheumatology for which no satisfactory treatment is yet available.

引用

页码：357 / 363

页数：7

共 48 条

[11] Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis [J].

Frey, Nicolas ;

Grange, Susan ;

Woodworth, Thasia .

JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (07) :754-766

[12] Tocilizumab Ameliorates Clinical Symptoms in Polymyalgia Rheumatica [J].

Hagihara, Keisuke ;

Kawase, Ichiro ;

Tanaka, Toshio ;

Kishimoto, Tadamitsu .

JOURNAL OF RHEUMATOLOGY, 2010, 37 (05) :1075-1076

[13] Tocilizumab improves cardiac disease in a hemodialysis patient with AA amyloidosis secondary to rheumatoid arthritis [J].

Hattori, Yoshinari ;

Ubara, Yoshifumi ;

Sumida, Keiichi ;

Hiramatsu, Rikako ;

Hasegawa, Eiko ;

Yamanouchi, Masayuki ;

Hayami, Noriko ;

Suwabe, Tatsuya ;

Hoshino, Junichi ;

Sawa, Naoki ;

Oohashi, Kenichi ;

Takaichi, Kenmei .

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2012, 19 (01) :37-40

[14]

Hench PS., 1949, Annals of the Rheumatic Diseases, V8, P97

[15] Mixed response to tocilizumab for ankylosing spondylitis [J].

Henes, Joerg C. ;

Horger, Marius ;

Guenaydin, Ilhan ;

Kanz, Lothar ;

Koetter, Ina .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (12) :2217-2218

[16] Tocilizumab in Systemic Lupus Erythematosus Data on Safety, Preliminary Efficacy, and Impact on Circulating Plasma Cells From an Open-Label Phase I Dosage-Escalation Study [J].

Illei, Gabor G. ;

Shirota, Yuko ;

Yarboro, Cheryl H. ;

Daruwalla, Jimmy ;

Tackey, Edward ;

Takada, Kazuki ;

Fleisher, Thomas ;

Balow, James E. ;

Lipsky, Peter E. .

ARTHRITIS AND RHEUMATISM, 2010, 62 (02) :542-552

[17] Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis [J].

Inoue, Daichi ;

Arima, Hiroshi ;

Kawanami, Chiharu ;

Takiuchi, Yoko ;

Nagano, Seiji ;

Kimura, Takaharu ;

Shimoji, Sonoko ;

Mori, Minako ;

Tabata, Sumie ;

Yanagita, Soshi ;

Matsushita, Akiko ;

Nagai, Kenichi ;

Imai, Yukihiro ;

Takahashi, Takayuki .

CLINICAL RHEUMATOLOGY, 2010, 29 (10) :1195-1197

[18] Combined treatment of giant-cell arteritis with methotrexate and prednisone -: A randomized, double-blind, placebo-controlled trial [J].

Jover, JA ;

Hernández-García, C ;

Morado, IC ;

Vargas, E ;

Bañares, A ;

Fernández-Gutiérrez, B .

ANNALS OF INTERNAL MEDICINE, 2001, 134 (02) :106-114

[19] Tocilizumab - A novel therapy for non-organ-specific autoimmune diseases [J].

Kaly, Lisa ;

Rosner, Itzhak .

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2012, 26 (01) :157-165

[20] Multiple myeloma: Charging toward a bright future [J].

Katzel, Jed A. ;

Hari, Parameswaran ;

Vesole, David H. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (05) :301-318

← 1 2 3 4 5 →